{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:18:52Z","timestamp":1790763532452,"version":"4.1.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/brain\/aws105","type":"journal-article","created":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T06:18:18Z","timestamp":1336198698000},"page":"1819-1833","source":"Crossref","is-referenced-by-count":119,"title":["Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis"],"prefix":"10.1093","volume":"135","author":[{"given":"Christina","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Jarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Stroet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Willison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Meinl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Linington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"key\n\t\t\t\t20170425182105_aws105-B1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.119.2.303","article-title":"The application of tissue culture to the study of experimental allergic encephalomyelitis. II Serum factors responsible for demyelination","volume":"119","author":"Appel","year":"1964","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20170425182105_aws105-B2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-2236(00)01575-7","article-title":"Pathogenetic role of autoantibodies in neurological diseases","volume":"23","author":"Archelos","year":"2000","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t20170425182105_aws105-B3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1083\/jcb.4.5.499","article-title":"Serial observations on patterns of growth, myelin formation, maintenance and degeneration in cultures of newborn rat and kitten cerebellum","volume":"4","author":"Bornstein","year":"1958","journal-title":"J Biophys Biochem Cytol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2006.03.014","article-title":"Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients","volume":"176","author":"Breij","year":"2006","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to Native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/oxfordjournals.bmb.a071396","article-title":"Humoral factors involved in immune processes in multiple sclerosis and allergic encephalomyelitis","volume":"33","author":"Caspary","year":"1977","journal-title":"Brit Med Bull"},{"key":"key\n\t\t\t\t20170425182105_aws105-B9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"2002) Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr Biol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B10","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1073\/pnas.0901496106","article-title":"Contactin-2\/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals","volume":"106","author":"Derfuss","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425182105_aws105-B11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00109-010-0632-3","article-title":"Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter","volume":"88","author":"Derfuss","year":"2010","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t20170425182105_aws105-B12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/rheumatology\/keh446","article-title":"Prospects for B-cell-targeted therapy in autoimmune disease","volume":"44","author":"Edwards","year":"2005","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B13","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1212\/01.WNL.0000147259.34163.33","article-title":"Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis","volume":"63","author":"Gaertner","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170425182105_aws105-B15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","article-title":"Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines","volume":"58","author":"Goodin","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1212\/WNL.30.7.749","article-title":"Multiple sclerosis: serum gamma globulin and demyelination in organ culture","volume":"30","author":"Grundke-Iqbal","year":"1980","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0165-5728(00)00462-8","article-title":"The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls","volume":"114","author":"Haase","year":"2001","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"New Eng J Med"},{"key":"key\n\t\t\t\t20170425182105_aws105-B19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.it.2007.11.002","article-title":"Resistance is futile: anti-neuronal autoimmunity in multiple sclerosis","volume":"29","author":"Huizinga","year":"2008","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.1111","article-title":"T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"36","author":"Iglesias","year":"2001","journal-title":"Glia"},{"key":"key\n\t\t\t\t20170425182105_aws105-B22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(03)00131-0","article-title":"Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis","volume":"139","author":"Ilyas","year":"2003","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2011.05.012","article-title":"Autoimmune disorders affecting both the central and peripheral nervous system","volume":"11","author":"Kamm","year":"2012","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t20170425182105_aws105-B25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1344","article-title":"Lipid microarrays identify key mediators of autoimmune brain inflammation","volume":"12","author":"Kanter","year":"2006","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170425182105_aws105-B26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425182105_aws105-B28","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1073\/pnas.0510672103","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis","volume":"103","author":"Lalive","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425182105_aws105-B29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458510389220","article-title":"Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children","volume":"17","author":"Lalive","year":"2011","journal-title":"Mult Scler"},{"key":"key\n\t\t\t\t20170425182105_aws105-B30","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/01.WNL.0000127615.15768.AE","article-title":"Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects","volume":"62","author":"Lampasona","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B31","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study of B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arth Rheum"},{"key":"key\n\t\t\t\t20170425182105_aws105-B32","first-page":"423","article-title":"The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane","volume":"66","author":"Lebar","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B33","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425182105_aws105-B34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/awh031","article-title":"Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study","volume":"127","author":"Lily","year":"2004","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425182105_aws105-B35","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/brain\/122.11.2089","article-title":"Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein","volume":"122","author":"Lindert","year":"1999","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425182105_aws105-B36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-5728(87)90031-2","article-title":"Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin\/oligodendrocyte glycoprotein (MOG)","volume":"17","author":"Linington","year":"1987","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B38","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin oligodendrocyte glycoprotein","volume":"130","author":"Linington","year":"1988","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuroinflam"},{"key":"key\n\t\t\t\t20170425182105_aws105-B41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archneurol.2011.34","article-title":"Beneficial plasma exchange response in central nervous system inflammatory demyelination","volume":"68","author":"Magana","year":"2011","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B44","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20170425182105_aws105-B45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B46","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.0801888","article-title":"Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis","volume":"183","author":"McLaughlin","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jns.2010.08.009","article-title":"Humoral autoimmunity in multiple sclerosis","volume":"306","author":"Meinl","year":"2011","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170425182105_aws105-B49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/1531-8249(200009)48:3<362::AID-ANA11>3.0.CO;2-6","article-title":"Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination","volume":"48","author":"Niehaus","year":"2000","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.1973.tb07519.x","article-title":"Myelination in rat brain- method of myelin isolation","volume":"21","author":"Norton","year":"1973","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425182105_aws105-B51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jocn.2003.12.013","article-title":"The pathogenesis of primary progressivie multiple sclerosis: antibody-mediated attack and no repair?","volume":"11","author":"Pender","year":"2004","journal-title":"J Clin Neurosci"},{"key":"key\n\t\t\t\t20170425182105_aws105-B52","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"143","author":"Piddlesden","year":"1993","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B54","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B55","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Probstel","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B56","doi-asserted-by":"crossref","first-page":"18889","DOI":"10.1073\/pnas.0806310105","article-title":"Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis","volume":"105","author":"Quintana","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425182105_aws105-B57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K","article-title":"Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation","volume":"46","author":"Raine","year":"1999","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1083\/jcb.200102086","article-title":"Sodium channel beta 1 and beta 3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain","volume":"154","author":"Ratcliffe","year":"2001","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B59","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/122.11.2047","article-title":"Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study","volume":"122","author":"Reindl","year":"1999","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425182105_aws105-B60","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425182105_aws105-B61","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/WCO.0b013e32830b84b7","article-title":"Ganglioside antibodies and neuropathies","volume":"21","author":"Rinaldi","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B62","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1523\/JNEUROSCI.23-18-07001.2003","article-title":"Paranodal interactions regulate expression of sodium channel subtypes and provide a diffusion barrier for the node of Ranvier","volume":"23","author":"Rios","year":"2003","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170425182105_aws105-B63","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.139.12.4016","article-title":"A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease","volume":"139","author":"Schluesener","year":"1987","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0014-4886(68)90148-9","article-title":"The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen","volume":"22","author":"Seil","year":"1968","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ana.410020417","article-title":"Tissue-culture studies of demyelinating disease: a critical review","volume":"2","author":"Seil","year":"1977","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B66","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.1976.00500060024006","article-title":"Neuroelectric blocking factors in multiple sclerosis and normal human sera","volume":"33","author":"Seil","year":"1976","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B67","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/glia.20650","article-title":"Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro","volume":"56","author":"Sorensen","year":"2008","journal-title":"Glia"},{"key":"key\n\t\t\t\t20170425182105_aws105-B68","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1126\/science.49925","article-title":"Myelination inhibiting and neuroelectric blocking factors in experimental allergic encephalomyelitis","volume":"187","author":"Seil","year":"1975","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425182105_aws105-B69","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Ann Rev Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B70","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ni0901-762","article-title":"Multiple sclerosis: a two-stage disease","volume":"2","author":"Steinman","year":"2001","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B71","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","article-title":"Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology","volume":"8","author":"Storch","year":"1998","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B72","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.146.5.1490","article-title":"T-cell and B-cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis","volume":"146","author":"Sun","year":"1991","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B73","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1083\/jcb.150.3.657","article-title":"An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction","volume":"150","author":"Tait","year":"2000","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B74","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1460-9568.2008.06415.x","article-title":"Myelinated, synapsing cultures of murine spinal cord: validation as an in vitro model of the central nervous system","volume":"28","author":"Thomson","year":"2008","journal-title":"Eur J Neurosci"},{"key":"key\n\t\t\t\t20170425182105_aws105-B75","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1083\/jcb.200305078","article-title":"Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers","volume":"162","author":"Traka","year":"2003","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.137.2.459","article-title":"Differentiation and death of premyelinating oligodendrocytes in developing rodent brain","volume":"137","author":"Trapp","year":"1997","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jca.2920100402","article-title":"Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis","volume":"10","author":"Vamvakas","year":"1995","journal-title":"J Clin Apher"},{"key":"key\n\t\t\t\t20170425182105_aws105-B78","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psych"},{"key":"key\n\t\t\t\t20170425182105_aws105-B79","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/labinvest.2008.53","article-title":"Autoantibodies and neurodegeneration in multiple sclerosis","volume":"88","author":"Vyshkina","year":"2008","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t20170425182105_aws105-B80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170425182105_aws105-B82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jca.1010","article-title":"Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system","volume":"16","author":"Weinshenker","year":"2001","journal-title":"J Clin Apher"},{"key":"key\n\t\t\t\t20170425182105_aws105-B83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-5728(91)90014-X","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls","volume":"31","author":"Xiao","year":"1991","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170425182105_aws105-B84","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","article-title":"Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/135\/6\/1819\/13797445\/aws105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:01:17Z","timestamp":1713924077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/aws105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,5,4]]},"published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/aws105","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717955899.793461104","asserted-by":"object"}]},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,4]]}}}